WDM PON SYSTEM
    3.
    发明申请
    WDM PON SYSTEM 审中-公开
    WDM PON系统

    公开(公告)号:US20100111533A1

    公开(公告)日:2010-05-06

    申请号:US12533028

    申请日:2009-07-31

    CPC classification number: H04J14/0282 H04J14/0221

    Abstract: A Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes: a respective Optical Network Terminal (ONT) at each one of a plurality of customer sites, each ONT comprising an ONT Fabry Perot (F-P) laser for generating a respective broadband multi-mode uplink optical signal; and an Array Waveguide Grating (AWG) for receiving each broadband multi-mode uplink optical signal through a respective branch port, and for multiplexing a portion of each received broadband multi-mode uplink optical signal into a Wavelength Division Multiplexed (WDM) signal. Each ONT F-P laser is non-injection locked. A gain of each ONT F-P laser is sufficiently inhomogeneous that the modes of the respective broadband multi-mode uplink optical signal are independent. A filter function of the AWG includes a pass band that encompasses at least one mode of a broadband multi-mode uplink optical signal.

    Abstract translation: 波分复用无源光网络(WDM-PON)包括:在多个客户站点中的每一个处的相应的光网络终端(ONT),每个ONT包括ONT法布里珀罗(FP)激光器,用于产生相应的宽带多路复用 模式上行光信号; 以及用于通过相应的分支端口接收每个宽带多模式上行链路光信号的阵列波导光栅(AWG),以及用于将每个接收到的宽带多模式上行链路光信号的一部分多路复用为波分复用(WDM)信号。 每个ONT F-P激光器都是非注射锁定。 每个ONT F-P激光器的增益是非常不均匀的,使得各个宽带多模式上行链路光信号的模式是独立的。 AWG的滤波器功能包括包含宽带多模式上行链路光信号的至少一种模式的通带。

    COLOR FREE WDM PON BASED ON BROADBAND OPTICAL TRANSMITTERS
    5.
    发明申请
    COLOR FREE WDM PON BASED ON BROADBAND OPTICAL TRANSMITTERS 失效
    基于宽带光传输器的无色WDM PON

    公开(公告)号:US20110064410A1

    公开(公告)日:2011-03-17

    申请号:US12558848

    申请日:2009-09-14

    Abstract: A Wavelength Division Multiplexed Passive Optical Network (WDM-PON) includes a plurality of broadband light sources, each broadband light source being connected to receive a respective data signal and generating a corresponding modulated broadband optical signal. An Array Waveguide Grating (AWG) is connected for receiving each modulated broadband optical signal through a respective branch port and for generating a filtered broadband signal. The AWG implements a filter function comprising a respective pass-band associated with each branch port such that the filtered broadband signal exhibits a respective intensity peak associated with each pass-band. Each intensity peak is modulated with data from a respective one of the broadband light sources. A bandwidth of the respective modulated broadband optical signal generated by each broadband light source is at least equal to the width of a channel-band of the AWG.

    Abstract translation: 波分复用无源光网络(WDM-PON)包括多个宽带光源,每个宽带光源被连接以接收相应的数据信号并产生相应的调制宽带光信号。 阵列波导光栅(AWG)被连接用于通过相应的分支端口接收每个调制的宽带光信号并且用于产生滤波的宽带信号。 AWG实现包括与每个分支端口相关联的相应通带的滤波器功能,使得经滤波的宽带信号呈现与每个通带相关联的相应强度峰值。 每个强度峰值用来自宽带光源中的相应一个的数据进行调制。 由每个宽带光源产生的相应调制的宽带光信号的带宽至少等于AWG的信道带宽度。

    WDM PON RF OVERLAY ARCHITECTURE BASED ON QUANTUM DOT MULTI-WAVELENGTH LASER SOURCE
    6.
    发明申请
    WDM PON RF OVERLAY ARCHITECTURE BASED ON QUANTUM DOT MULTI-WAVELENGTH LASER SOURCE 有权
    基于量子多波长激光源的WDM PON射频覆盖架构

    公开(公告)号:US20100046946A1

    公开(公告)日:2010-02-25

    申请号:US12341012

    申请日:2008-12-22

    Applicant: Bin CAO Rong CHEN

    Inventor: Bin CAO Rong CHEN

    Abstract: In a Wavelength Division Multiplexed Passive Optical Network (WDM-PON) including, a system for overlaying an analog broadcast signal. An Optical Line Terminal of the WDM-PON includes a broadband light source for generating uplink seed light for each uplink channel of the WDM-PON, and a modulator for modulating the analog broadcast signal onto the uplink seed light. An Optical Network Terminal of the WDM-PON receives the uplink seed light from the Optical Line Terminal, and includes an optical divider for dividing the received seed light into a first signal and a second signal; a light source for generating an uplink data signals using the first signal as seed light; and an RF receiver for detecting the analog broadcast signal modulated on the second signal.

    Abstract translation: 在波分复用无源光网络(WDM-PON)中,包括用于覆盖模拟广播信号的系统。 WDM-PON的光线路终端包括用于为WDM-PON的每个上行链路信道生成上行链路种子光的宽带光源和用于将模拟广播信号调制到上行链路种子光的调制器。 WDM-PON的光网络终端从光线路终端接收上行种子光,并包括用于将接收到的种子光分为第一信号和第二信号的光分路器; 用于使用所述第一信号生成上行链路数据信号作为种子光的光源; 以及用于检测在第二信号上调制的模拟广播信号的RF接收机。

    SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
    7.
    发明申请
    SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF 有权
    取代的二羟基和四氢呋喃氧杂二恶嗪,其制备和使用

    公开(公告)号:US20100075994A1

    公开(公告)日:2010-03-25

    申请号:US12554129

    申请日:2009-09-04

    CPC classification number: C07D498/04

    Abstract: The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.

    Abstract translation: 本发明涉及一系列取代的二氢和四氢恶唑啉嘧啶酮,特别涉及一系列2-取代-2,3-二氢 - 恶唑并[3,2-a]嘧啶-7-酮和2-取代-2,2-二氧杂唑并[ (I)的3,5,6-四氢恶唑并[3,2-a]嘧啶-7-酮:其中p,n,X,Y,R1,R2,R3,R4,R5,R6, R7和R8如本文所定义。 本发明还涉及制备这些化合物的方法,包括新型中间体。 本发明的化合物是代谢型谷氨酸受体(mGluR),特别是mGluR2受体的调节剂。 因此,本发明的化合物可用作药物,特别是用于治疗和/或预防各种中枢神经系统疾病(CNS),包括但不限于急性和慢性神经变性疾病,精神病,抽搐,焦虑, 抑郁症,偏头痛,疼痛,睡眠障碍和呕吐。

    DISCRETELY TUNABLE LOCALLY SEEDED LASER DEVICE
    8.
    发明申请
    DISCRETELY TUNABLE LOCALLY SEEDED LASER DEVICE 审中-公开
    独特的TUNABLE本地种子激光器件

    公开(公告)号:US20140050237A1

    公开(公告)日:2014-02-20

    申请号:US13586090

    申请日:2012-08-15

    CPC classification number: H01S5/4006 H01S5/0064 H01S5/0078 H01S5/0612

    Abstract: A discretely tunable locally seeded laser device is provided. The discretely tunable locally seeded laser device comprises: a first tunable laser comprising first discrete output modes; and, a second tunable laser arranged to receive output from the first tunable laser, but otherwise optically isolated from the first tunable laser, the second tunable laser comprising second discrete output modes, such that one first discrete output mode can optically seed an aligned second discrete output mode in a given position of one or more of the first discrete output modes and the second discrete output modes, the aligned second discrete output mode comprising a dominant output.

    Abstract translation: 提供离散可调谐的本地种子激光器件。 离散可调本地种子激光器件包括:第一可调谐激光器,包括第一离散输出模式; 以及第二可调谐激光器,其布置成接收来自所述第一可调谐激光器的输出,但是否则与所述第一可调谐激光器光学隔离,所述第二可调谐激光器包括第二离散输出模式,使得一个第一离散输出模式可光学地种子对准的第二离散 输出模式在一个或多个第一离散输出模式和第二离散输出模式的给定位置中,所对齐的第二离散输出模式包括主要输出。

    TRACKING INJECTION SEEDING POWER BASED ON BACK FACET MONITORING (BFM) OF AN INJECTION SEEDED LASER
    9.
    发明申请
    TRACKING INJECTION SEEDING POWER BASED ON BACK FACET MONITORING (BFM) OF AN INJECTION SEEDED LASER 失效
    跟踪注射功率基于注射激光器的反面监测(BFM)

    公开(公告)号:US20110182307A1

    公开(公告)日:2011-07-28

    申请号:US13082690

    申请日:2011-04-08

    CPC classification number: H01S5/0683 H01S5/06804

    Abstract: A method of estimating an injection power of seed light injected into an injection-seeded transmitter. A back face monitoring (BFM) response of the injection-seeded transmitter is determined, and data representative of the BFM response stored in a memory. During run-time, a controller of the injection-seeded transmitter, detects a temperature of the injection-seeded transmitter and an instantaneous BFM current. BFM response data is obtained from the memory based on the detected temperature, and the seed light injection power estimated based on the obtained data and the detected instantaneous BFM current.

    Abstract translation: 一种估计注入种子发射机的种子光的注入功率的方法。 确定注入种子发送器的背面监视(BFM)响应,并将表示BFM响应的数据存储在存储器中。 在运行期间,注入种子发射机的控制器检测注入种子发射机的温度和瞬时BFM电流。 基于检测到的温度从存储器获得BFM响应数据,并且基于获得的数据估计的种子光注入功率和检测到的瞬时BFM电流。

    2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
    10.
    发明申请
    2,6-SUBSTITUTED-4-MONOSUBSTITUTEDAMINO-PYRIMIDINE AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS 失效
    作为前列腺素D2受体拮抗剂的2,6-取代的4-单核苷酸氨基嘧啶

    公开(公告)号:US20070265291A1

    公开(公告)日:2007-11-15

    申请号:US11735760

    申请日:2007-04-16

    Abstract: The present invention is directed to a compound of Formula (I) wherein Cy1, Cy2, L1, L2, and R1 are as defined herein, a pharmaceutical composition comprising a pharmaceutically effective amount of one or more compounds according to Formula (I) in admixture with a pharmaceutically acceptable carrier, and a method of treating a patient suffering from a PGD2-mediated disorder including, but not limited to, allergic disease (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (such as scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative colitis and the like by administering to said patient a pharmaceutically effective amount of a compound according to Formula (I).

    Abstract translation: 本发明涉及式(I)的化合物,其中Cy 1,Cy 2,L 1,L 2, R 1和R 2如本文所定义,药物组合物包含药学上有效量的一种或多种根据式(I)的化合物与药学上可接受的载体的混合物,和 治疗患有PGD2介导的病症的患者,包括但不限于过敏性疾病(例如过敏性鼻炎,过敏性结膜炎,特应性皮炎,支气管哮喘和食物过敏),系统性肥大细胞增多症,伴有系统性肥大细胞活化的病症,过敏反应 休克,支气管收缩,支气管炎,荨麻疹,湿疹,伴有瘙痒的疾病(例如特应性皮炎和荨麻疹),由于行为伴随而产生的疾病(例如白内障,视网膜脱离,炎症,感染和睡眠障碍) 痒(如刮伤 和殴打),炎症,慢性阻塞性肺疾病,缺血再灌注损伤,脑血管意外,慢性类风湿性关节炎,胸膜炎,溃疡性结肠炎等,通过向所述患者施用药学有效量的根据式(I)的化合物。

Patent Agency Ranking